First meeting of BRICS health ministers brings new leadership to global health

13 July 2011

Universal access to medicines was a key topic of discussion at a meeting this week of health ministers from Brazil, Russia, India, China and South Africa (BRICS) in Beijing, China. The meeting, hosted by the government of China, aimed to identify opportunities for BRICS countries to promote wider access to affordable, quality-assured medicines, with a view to reaching the Millennium Development Goals and other public health challenges.

“The five BRICS countries are bringing a new voice, a new perspective and new solutions to today’s global challenges,” said UNAIDS Executive Director Michel Sidibe who participated in the First BRICS Health Ministers’ Meeting, together with World Health Organization Director General Margaret Chan. “It is a voice with incredible economic, technological and innovative strength behind it and, at the same time, a voice intimately connected to the needs and interests of the developing world,” he added.

Brazil, Russia, India, China and South Africa are home to 40% of the global population and nearly one third of all people living with HIV in the world. While the five BRICS countries have made significant progress in expanding HIV prevention and treatment services for their populations, the goal of universal access remains a critical challenge: In four of five BRICS countries, for example, only one third of people who need HIV treatment are receiving it.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight





More Features in Generics